| HGNC Family | Non-coding RNAs |
| Name | microRNA 375 |
| Description | microRNAs (miRNAs) are short (20-24 nt) non-coding RNAs that are involved in post-transcriptional regulation of gene expression in multicellular organisms by affecting both the stability and translation of mRNAs. miRNAs are transcribed by RNA polymerase II as part of capped and polyadenylated primary transcripts (pri-miRNAs) that can be either protein-coding or non-coding. The primary transcript is cleaved by the Drosha ribonuclease III enzyme to produce an approximately 70-nt stem-loop precursor miRNA (pre-miRNA), which is further cleaved by the cytoplasmic Dicer ribonuclease to generate the mature miRNA and antisense miRNA star (miRNA*) products. The mature miRNA is incorporated into a RNA-induced silencing complex (RISC), which recognizes target mRNAs through imperfect base pairing with the miRNA and most commonly results in translational inhibition or destabilization of the target mRNA. The RefSeq represents the predicted microRNA stem-loop. [provided by RefSeq, Sep 2009] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nMicroRNA‐375 (miR-375) has emerged as a key regulator of tumor cell behavior in a variety of cancer types. In gastrointestinal malignancies such as gastric cancer and hepatocellular carcinoma, miR-375 is frequently down‐regulated, thereby relieving its inhibition on oncogenic drivers such as JAK2, YAP1, and other components of the Hippo pathway. This loss contributes to increased cell proliferation, migration, and invasion. In addition, reduced miR-375 levels have been observed in colorectal, oral, cervical cancers and melanoma, where its diminished expression leads to upregulation of targets including AEG-1/MTDH and CIP2A, while in some neuroendocrine lung cancers its aberrant upregulation has been linked to differentiation processes."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "11"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn contrast, in certain contexts miR-375 can display oncogenic features. For instance, in estrogen receptor–positive breast cancer high levels of miR-375 drive cell proliferation by modulating a forward feedback loop via suppression of RASD1, whereas its restoration in tamoxifen-resistant cells can re-sensitize them via partial reversal of epithelial-to-mesenchymal transition through targets such as MTDH and SHOX2. In prostate cancer, elevated miR-375 appears to promote tumor progression by downregulating targets like SEC23A and, together with other miRNAs, by dampening tumor suppressors such as CIC to influence epithelial plasticity. Beyond its roles in cancer cells, miR-375 is essential for pancreatic islet development and insulin secretion; its precise control is key for maintaining proper β- and α-cell balance, and alterations in its expression have been linked to both type 1 and type 2 diabetes. In addition, circulating levels of miR-375 are being evaluated as promising diagnostic and prognostic biomarkers in malignancies such as metastatic prostate and esophageal squamous cell carcinoma and may also serve as predictors of chemoresistance."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "12", "end_ref": "25"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nEmerging studies have further broadened the functional landscape of miR-375. High-resolution genomic approaches have revealed focal DNA alterations involving the miR-375 locus in premalignant lesions, indicating its potential involvement early in neoplastic transformation. Moreover, investigations in metabolic disease models and analyses of exosomal miRNA profiles underscore the utility of miR-375 as a minimally invasive biomarker in both oncologic and diabetic contexts. Additional reports—ranging from examinations of microRNA regulatory networks in esophageal squamous and triple-negative breast cancers, to studies in osteosarcoma and autoimmune thyroid disorders—reinforce the multifaceted contributions of miR-375 not only to cancer biology but also to processes such as cell differentiation, immune modulation, and alternative splicing."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "26", "end_ref": "34"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Ling Ding, Yanjun Xu, Wei Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MiR-375 frequently downregulated in gastric cancer inhibits cell proliferation by targeting JAK2."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Res (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/cr.2010.79"}], "href": "https://doi.org/10.1038/cr.2010.79"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20548334"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20548334"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "X-X He, Y Chang, F-Y Meng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2011.500"}], "href": "https://doi.org/10.1038/onc.2011.500"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22056881"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22056881"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Angela M Liu, Ronnie T P Poon, John M Luk "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Biochem Biophys Res Commun (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.bbrc.2010.03.036"}], "href": "https://doi.org/10.1016/j.bbrc.2010.03.036"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20226166"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20226166"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Petra Faltejskova, Marek Svoboda, Klara Srutova, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification and functional screening of microRNAs highly deregulated in colorectal cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Mol Med (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/j.1582-4934.2012.01579.x"}], "href": "https://doi.org/10.1111/j.1582-4934.2012.01579.x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22469014"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22469014"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Nijiro Nohata, Toyoyuki Hanazawa, Naoko Kikkawa, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC)."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Hum Genet (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/jhg.2011.66"}], "href": "https://doi.org/10.1038/jhg.2011.66"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21753766"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21753766"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Wei Kang, Tingting Huang, Yuhang Zhou, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Death Dis (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/s41419-017-0134-0"}], "href": "https://doi.org/10.1038/s41419-017-0134-0"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29367737"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29367737"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Yixuan Liu, Rui Xing, Xiaodong Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-375 targets the p53 gene to regulate cellular response to ionizing radiation and etoposide in gastric cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "DNA Repair (Amst) (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.dnarep.2013.06.002"}], "href": "https://doi.org/10.1016/j.dnarep.2013.06.002"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23835407"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23835407"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Chaohui Wu, Minjie Li, Chao Hu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Clinical significance of serum miR-223, miR-25 and miR-375 in patients with esophageal squamous cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Biol Rep (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1007/s11033-013-2970-z"}], "href": "https://doi.org/10.1007/s11033-013-2970-z"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24390317"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24390317"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Mariska Bierkens, Oscar Krijgsman, Saskia M Wilting, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Focal aberrations indicate EYA2 and hsa-miR-375 as oncogene and tumor suppressor in cervical carcinogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genes Chromosomes Cancer (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/gcc.22006"}], "href": "https://doi.org/10.1002/gcc.22006"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22987659"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22987659"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Joseph Mazar, Dan DeBlasio, Subramaniam S Govindarajan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Epigenetic regulation of microRNA-375 and its role in melanoma development in humans."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "FEBS Lett (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.febslet.2011.06.025"}], "href": "https://doi.org/10.1016/j.febslet.2011.06.025"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21723283"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21723283"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Florin Zaharie, Mihai Stefan Muresan, Bobe Petrushev, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Exosome-Carried microRNA-375 Inhibits Cell Progression and Dissemination via Bcl-2 Blocking in Colon Cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Gastrointestin Liver Dis (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.15403/jgld.2014.1121.244.375"}], "href": "https://doi.org/10.15403/jgld.2014.1121.244.375"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26697569"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26697569"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Pedro de Souza Rocha Simonini, Achim Breiling, Nibedita Gupta, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Epigenetically deregulated microRNA-375 is involved in a positive feedback loop with estrogen receptor alpha in breast cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-10-1318"}], "href": "https://doi.org/10.1158/0008-5472.CAN-10-1318"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20978187"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20978187"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "A Ward, A Balwierz, J D Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Re-expression of microRNA-375 reverses both tamoxifen resistance and accompanying EMT-like properties in breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2012.128"}], "href": "https://doi.org/10.1038/onc.2012.128"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22508479"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22508479"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Xueling Li "}, {"type": "b", "children": [{"type": "t", "text": "MiR-375, a microRNA related to diabetes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gene (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.gene.2013.09.105"}], "href": "https://doi.org/10.1016/j.gene.2013.09.105"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24120394"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24120394"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Hailu Zhao, Jing Guan, Heung-Man Lee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Up-regulated pancreatic tissue microRNA-375 associates with human type 2 diabetes through beta-cell deficit and islet amyloid deposition."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Pancreas (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1097/MPA.0b013e3181d12613"}], "href": "https://doi.org/10.1097/MPA.0b013e3181d12613"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20467341"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20467341"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Sungguan Hong, Hyangsoon Noh, Yong Teng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "SHOX2 is a direct miR-375 target and a novel epithelial-to-mesenchymal transition inducer in breast cancer cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Neoplasia (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.neo.2014.03.010"}], "href": "https://doi.org/10.1016/j.neo.2014.03.010"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24746361"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24746361"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Katherine A Pillman, Caroline A Phillips, Suraya Roslan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-200/375 control epithelial plasticity-associated alternative splicing by repressing the RNA-binding protein Quaking."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "EMBO J (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.15252/embj.201899016"}], "href": "https://doi.org/10.15252/embj.201899016"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "29871889"}], "href": "https://pubmed.ncbi.nlm.nih.gov/29871889"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Akira Watahiki, Robyn J Macfarlane, Martin E Gleave, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Plasma miRNAs as biomarkers to identify patients with castration-resistant metastatic prostate cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Int J Mol Sci (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.3390/ijms14047757"}], "href": "https://doi.org/10.3390/ijms14047757"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23574937"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23574937"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Nahyun Choi, Jongmin Park, Jeon-Soo Lee, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-93/miR-106b/miR-375-CIC-CRABP1: a novel regulatory axis in prostate cancer progression."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncotarget (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.18632/oncotarget.4372"}], "href": "https://doi.org/10.18632/oncotarget.4372"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26124181"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26124181"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "L A Selth, R Das, S L Townley, et al. "}, {"type": "b", "children": [{"type": "t", "text": "A ZEB1-miR-375-YAP1 pathway regulates epithelial plasticity in prostate cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Oncogene (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/onc.2016.185"}], "href": "https://doi.org/10.1038/onc.2016.185"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27270433"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27270433"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Johannes Denk, Kai Boelmans, Christine Siegismund, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s Disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0126423"}], "href": "https://doi.org/10.1371/journal.pone.0126423"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25992776"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25992776"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Yuan Wang, Rachel Lieberman, Jing Pan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "miR-375 induces docetaxel resistance in prostate cancer by targeting SEC23A and YAP1."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12943-016-0556-9"}], "href": "https://doi.org/10.1186/s12943-016-0556-9"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27832783"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27832783"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Shuhei Komatsu, Daisuke Ichikawa, Hiroki Takeshita, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Prognostic impact of circulating miR-21 and miR-375 in plasma of patients with esophageal squamous cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Expert Opin Biol Ther (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1517/14712598.2012.681373"}], "href": "https://doi.org/10.1517/14712598.2012.681373"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22519435"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22519435"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Mu Li, Alex J Rai, G Joel DeCastro, et al. "}, {"type": "b", "children": [{"type": "t", "text": "An optimized procedure for exosome isolation and analysis using serum samples: Application to cancer biomarker discovery."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Methods (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.ymeth.2015.03.009"}], "href": "https://doi.org/10.1016/j.ymeth.2015.03.009"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25814440"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25814440"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Rom S Leidner, Lakshmeswari Ravi, Patrick Leahy, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The microRNAs, MiR-31 and MiR-375, as candidate markers in Barrett's esophageal carcinogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Genes Chromosomes Cancer (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/gcc.21934"}], "href": "https://doi.org/10.1002/gcc.21934"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22302717"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22302717"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "X Zhang, Z Yan, J Zhang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Combination of hsa-miR-375 and hsa-miR-142-5p as a predictor for recurrence risk in gastric cancer patients following surgical resection."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Ann Oncol (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1093/annonc/mdq758"}], "href": "https://doi.org/10.1093/annonc/mdq758"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21343377"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21343377"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Chigusa Higuchi, Atsuko Nakatsuka, Jun Eguchi, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Identification of circulating miR-101, miR-375 and miR-802 as biomarkers for type 2 diabetes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Metabolism (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.metabol.2014.12.003"}], "href": "https://doi.org/10.1016/j.metabol.2014.12.003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25726255"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25726255"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Linda Fabris, Yvonne Ceder, Arul M Chinnaiyan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The Potential of MicroRNAs as Prostate Cancer Biomarkers."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur Urol (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.eururo.2015.12.054"}], "href": "https://doi.org/10.1016/j.eururo.2015.12.054"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26806656"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26806656"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "S Komatsu, D Ichikawa, H Takeshita, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Br J Cancer (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/bjc.2011.198"}], "href": "https://doi.org/10.1038/bjc.2011.198"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21673684"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21673684"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Kar Lok Kong, Dora Lai Wan Kwong, Tim Hon-Man Chan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "MicroRNA-375 inhibits tumour growth and metastasis in oesophageal squamous cell carcinoma through repressing insulin-like growth factor 1 receptor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gut (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1136/gutjnl-2011-300178"}], "href": "https://doi.org/10.1136/gutjnl-2011-300178"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21813472"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21813472"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Hailin Tang, Xiaojia Huang, Jin Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "circKIF4A acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancer."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12943-019-0946-x"}], "href": "https://doi.org/10.1186/s12943-019-0946-x"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30744636"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30744636"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Gang Liu, Kangmao Huang, Zhiwei Jie, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CircFAT1 sponges miR-375 to promote the expression of Yes-associated protein 1 in osteosarcoma cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Mol Cancer (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/s12943-018-0917-7"}], "href": "https://doi.org/10.1186/s12943-018-0917-7"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30514309"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30514309"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Xing-Ming Ye, Hua-Yu Zhu, Wen-Dong Bai, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Epigenetic silencing of miR-375 induces trastuzumab resistance in HER2-positive breast cancer by targeting IGF1R."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "BMC Cancer (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1186/1471-2407-14-134"}], "href": "https://doi.org/10.1186/1471-2407-14-134"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24571711"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24571711"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Hiroya Yamada, Mitsuyasu Itoh, Izumi Hiratsuka, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Circulating microRNAs in autoimmune thyroid diseases."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Clin Endocrinol (Oxf) (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/cen.12432"}], "href": "https://doi.org/10.1111/cen.12432"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24533739"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24533739"}]}]}]}
|
| Synonyms | MIR-375, MIRN375, MIRNA375, HSA-MIR-375 |
| NCBI Gene ID | 494324 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
MIR375 has 1,345 functional associations with biological entities spanning 6 categories (molecular profile, disease, phenotype or trait, functional term, phrase or reference, chemical, cell line, cell type or tissue, gene, protein or microRNA) extracted from 18 datasets.
Click the + buttons to view associations for MIR375 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR375 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR375 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of MIR375 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| CTD Gene-Disease Associations | diseases associated with MIR375 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR375 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of MIR375 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of MIR375 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with MIR375 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing MIR375 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of MIR375 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of MIR375 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of MIR375 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of MIR375 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| MGI Mouse Phenotype Associations 2023 | phenotypes of transgenic mice caused by MIR375 gene mutations from the MGI Mouse Phenotype Associations 2023 dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of MIR375 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MPO Gene-Phenotype Associations | phenotypes of transgenic mice caused by MIR375 gene mutations from the MPO Gene-Phenotype Associations dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at MIR375 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| WikiPathways Pathways 2014 | pathways involving MIR375 protein from the Wikipathways Pathways 2014 dataset. | |